Try
Medtronic plc
MDTUnited States
81 filed reports · 680 financial concepts · 42 earnings calls · 15 media appearances
Filed reports
81 reports · Jan 2016 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 178 guidance figures, 38 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 38 | 176 | Apr 2016 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 32 | 8,442 | Jan 2016 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 11 | 8,463 | Apr 2016 to Apr 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2027 Q1 | 10-Q | Jul 31, 2026 | Sep 3, 2026 | 520 | Open |
| FY2027 Q1 | 8-K | Jul 31, 2026 | Sep 1, 2026 | 4 | Open |
| FY2026 | 10-K | Apr 24, 2026 | Jun 18, 2026 | 1,370 | Open |
| FY2026 Q4 | 8-K | Apr 24, 2026 | Jun 3, 2026 | 6 | Open |
| FY2026 Q3 | 10-Q | Jan 23, 2026 | Feb 24, 2026 | 454 | Open |
| FY2026 Q3 | 8-K | Jan 23, 2026 | Feb 17, 2026 | 4 | Open |
| FY2026 Q2 | 10-Q | Oct 24, 2025 | Nov 25, 2025 | 381 | Open |
| FY2026 Q2 | 8-K | Oct 24, 2025 | Nov 18, 2025 | 4 | Open |
| FY2026 Q1 | 10-Q | Jul 25, 2025 | Aug 26, 2025 | 268 | Open |
| FY2026 Q1 | 8-K | Jul 25, 2025 | Aug 19, 2025 | 4 | Open |
| FY2025 | 10-K | Apr 25, 2025 | Jun 20, 2025 | 795 | Open |
| FY2025 Q4 | 8-K | Apr 25, 2025 | May 21, 2025 | 6 | Open |
Financial data
680 concepts · 17,081 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial635 concepts · 13,519 facts · Apr 2014 to Jul 2026
- Net income loss62 · Apr 2014 to Jul 2026
- Revenue62 · Apr 2014 to Jul 2026
- Cash and cash equivalents at carrying value61 · Apr 2014 to Jul 2026
- Allocated share based compensation expense60 · Apr 2014 to Jul 2026
- Amortization of intangible assets60 · Apr 2014 to Jul 2026
- Comprehensive income net of tax60 · Apr 2014 to Jul 2026
- Cost of goods and services sold (US GAAP)60 · Apr 2014 to Jul 2026
- Income tax expense benefit60 · Apr 2014 to Jul 2026
- Operating income loss60 · Apr 2014 to Jul 2026
- Other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax60 · Apr 2014 to Jul 2026
- Other comprehensive income loss net of tax60 · Apr 2014 to Jul 2026
- Other comprehensive income loss pension and other postretirement benefit plans adjustment net of tax60 · Apr 2014 to Jul 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax60 · Apr 2014 to Jul 2026
- Research and development expense excluding acquired in process cost60 · Apr 2014 to Jul 2026
- Restructuring charges, net60 · Apr 2014 to Jul 2026
- Selling general and administrative expense60 · Apr 2014 to Jul 2026
- Accumulated other comprehensive income loss net of tax59 · Apr 2014 to Jul 2026
- Allocated share based compensation expense net of tax59 · Apr 2014 to Apr 2026
- Business combination contingent consideration liability59 · Apr 2014 to Jul 2026
- Deferred income taxes and tax credits59 · Apr 2014 to Jul 2026
- Depreciation depletion and amortization59 · Apr 2014 to Jul 2026
- Employee service share based compensation tax benefit from compensation expense59 · Apr 2014 to Apr 2026
- Income taxes paid net59 · Apr 2014 to Jul 2026
- Increase decrease in accounts and notes receivable59 · Apr 2014 to Jul 2026
Segment32 concepts · 2,941 facts · Apr 2014 to Jul 2026
- Revenue1,383 · Apr 2014 to Jul 2026
- Goodwill227 · Apr 2015 to Apr 2026
- Operating income loss206 · Apr 2018 to Jul 2026
- Goodwill foreign currency translation gain loss197 · Apr 2016 to Jul 2026
- Goodwill acquired during period146 · Jul 2016 to Jul 2026
- Goodwill purchase accounting adjustments134 · Jul 2017 to Jul 2026
- Depreciation104 · Apr 2016 to Jul 2026
- Total Assets79 · Apr 2015 to Apr 2026
- Cost of goods and services sold (US GAAP)49 · Apr 2023 to Jul 2026
- Research and development expense excluding acquired in process cost49 · Apr 2023 to Jul 2026
- Segment reporting other item amount49 · Apr 2023 to Jul 2026
- Selling general and administrative expense49 · Apr 2023 to Jul 2026
- Reportable segments48 · Apr 2016 to Apr 2019
- Revenue (excluding assessed tax)42 · Apr 2023 to Apr 2026
- Income loss from continuing operations before income taxes minority interest and income loss from equity method investments40 · Jan 2015 to Jan 2018
- Goodwill translation adjustments20 · Apr 2015 to Oct 2016
- Impairment of intangible assets finitelived18 · Jan 2019 to Apr 2022
- Impairment of intangible assets indefinitelived excluding goodwill18 · Jan 2018 to Apr 2023
- Goodwill transfers16 · Apr 2017 to Jan 2023
- Operating Segments16 · Apr 2014 to Apr 2017
- Cardiovascular8 · Jul 2021 to Jul 2026
- Goodwill other changes8 · Apr 2015 to Apr 2016
- Other nonrecurring income expense8 · Jan 2025 to Apr 2026
- Goodwill written off related to sale of business unit7 · Apr 2023
Geography4 concepts · 433 facts · Apr 2014 to Jul 2026
- Revenue379 · Apr 2014 to Jul 2026
- Property, Plant & Equipment, Net44 · Apr 2015 to Apr 2026
- Contract with customer liability revenue recognized5 · Jul 2024 to Apr 2025
- Increase decrease in contract with customer liability5 · Jul 2025 to Apr 2026
Guidance7 concepts · 176 facts · May 2016 to Sep 2026
- Revenue Growth Guidance72 · May 2016 to Sep 2026
- EPS (Diluted) Guidance62 · May 2016 to Sep 2026
- EPS (Diluted) Growth Guidance18 · Aug 2016 to Jun 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))8 · Aug 2023 to May 2024
- Revenue Growth Guidance (Organic)8 · Aug 2023 to May 2024
- Free Cash Flow Guidance6 · Nov 2016 to Feb 2019
- EPS (Diluted) Growth Guidance (Adjusted (non-GAAP))2 · May 2024
Product2 concepts · 12 facts · Apr 2017 to Apr 2026
- Cost of goods and services sold (US GAAP)6 · Apr 2017 to Apr 2022
- Selling general and administrative expense6 · Apr 2021 to Apr 2026
Segments
3,386 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments24 members · 2,491 facts
- Cardiovascular491 · Apr 2014 to Jul 2026
- Neuroscience Group461 · Apr 2014 to Jul 2026
- Medical Surgical456 · Apr 2014 to Jul 2026
- Diabetes Group418 · Apr 2014 to Jul 2026
- All Other Segments90 · Apr 2022 to Jul 2026
- Cardiovascular70 · Apr 2015 to Apr 2026
- Medical surgical66 · Apr 2015 to Apr 2026
- Neuroscience group66 · Apr 2015 to Apr 2026
- Diabetes group64 · Apr 2015 to Jan 2026
- Neuroscience Portfolio51 · Apr 2019 to Apr 2023
- Medical Surgical Portfolio44 · Apr 2019 to Apr 2023
- Diabetes Operating Unit43 · Apr 2019 to Apr 2023
- Total reportable segments42 · Apr 2023 to Apr 2026
- Other42 · Jul 2022 to Apr 2025
- Cardiovascular Portfolio29 · Apr 2019 to Apr 2021
- Other Operating Segments Including Diabetes13 · Apr 2024 to Jul 2026
- Diabetes operating unit8 · Apr 2020 to Apr 2023
- Medical surgical portfolio8 · Apr 2020 to Apr 2023
- Neuroscience portfolio8 · Apr 2020 to Apr 2023
- All other segments8 · Apr 2023 to Apr 2026
- Other Operating Segment Misc5 · Apr 2024 to Jul 2026
- Cardiovascular portfolio4 · Apr 2020 to Apr 2021
- Other operating segments including diabetes2 · Apr 2025 to Apr 2026
- Reportable segment aggregation before other operating segment2 · Apr 2025 to Apr 2026
Subsegments23 members · 450 facts
- Specialty Therapies Division49 · Apr 2017 to Jul 2026
- Cardiac Rhythmand Heart Failure Division40 · Apr 2017 to Apr 2025
- Cranial And Spinal Technologies Division37 · Apr 2019 to Jul 2026
- Neuromodulation Division37 · Apr 2019 to Jul 2026
- Surgical Innovations Division36 · Apr 2017 to Apr 2025
- Coronary And Peripheral Vascular Division34 · Apr 2019 to Apr 2026
- Structural Heart And Aortic Division34 · Apr 2019 to Apr 2026
- Respiratory Gastrointestinaland Renal Division25 · Apr 2017 to Jan 2023
- Aortic Peripheraland Venous Division19 · Apr 2017 to Jan 2021
- Coronaryand Structural Heart Division19 · Apr 2017 to Jan 2021
- Surgical Endoscopy19 · Jul 2022 to Jul 2026
- Acute Care Monitoring18 · Apr 2022 to Jul 2026
- Brain Therapies Division16 · Apr 2017 to Apr 2020
- Pain Therapies Division16 · Apr 2017 to Apr 2020
- Spine Division16 · Apr 2017 to Apr 2020
- Cardiac Rhythm And Heart Failure Division15 · Jul 2023 to Apr 2026
- Patient Monitoring And Respiratory Interventions6 · Jul 2022 to Jan 2024
- Respiratory Gastrointestinal And Renal Division5 · Apr 2019 to Apr 2023
- Cardio Vascular Surgery Division2 · Jul 2025 to Jul 2026
- Electrophysiology Therapies Division2 · Jul 2025 to Jul 2026
- Interventional Cardiology Therapies Division2 · Jul 2025 to Jul 2026
- Peripheral Vascular Health Division2 · Jul 2025 to Jul 2026
- Surgical Technologies Division1 · Jan 2015
Statement geographicalsrt:StatementGeographicalAxis9 members · 293 facts
- IE47 · Apr 2017 to Jul 2026
- Total Other Countries Excluding Ireland47 · Apr 2017 to Jul 2026
- Total Other Countries Excluding United Statesand Ireland47 · Apr 2017 to Jul 2026
- US47 · Apr 2017 to Jul 2026
- Japan Australia New Zealand Korea Canadaand Western Europe36 · Apr 2017 to Apr 2024
- Middle East Africa Latin America Eastern Europeand Asia Excluding Japanand Korea36 · Apr 2017 to Apr 2024
- Non Us17 · Apr 2023 to Jul 2026
- IT10 · Jul 2024 to Apr 2026
- Total Other Countries Excluding United States And Ireland6 · Jul 2023 to Jan 2025
Statement geographicalus-gaap:StatementGeographicalAxis15 members · 140 facts
- US19 · Apr 2014 to Apr 2018
- Americas17 · Apr 2014 to Jan 2018
- Asia Pacific17 · Apr 2014 to Jan 2018
- CN17 · Apr 2014 to Jan 2018
- EMEA17 · Apr 2014 to Jan 2018
- Us12 · Apr 2015 to Apr 2026
- Ie11 · Apr 2015 to Apr 2026
- Total other countries excluding united statesand ireland9 · Apr 2018 to Apr 2026
- Cn3 · Apr 2015 to Apr 2017
- IE3 · Apr 2016 to Apr 2018
- Total Other Countries Excluding Ireland3 · Apr 2016 to Apr 2018
- Total Other Countries Excluding United Statesand Ireland3 · Apr 2016 to Apr 2018
- Americas3 · Apr 2015 to Apr 2017
- Asia pacific3 · Apr 2015 to Apr 2017
- Emea3 · Apr 2015 to Apr 2017
Product or service1 member · 12 facts
- Shipping And Handling12 · Apr 2017 to Apr 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary105 claims from 8 reports · Oct 2024 to Jul 2026
- Management discussion (MD&A) commentary201 claims from 8 reports · Oct 2024 to Jul 2026
- Risk-factor changes18 claims from 1 reports · Apr 2026
- Risk factors69 risks from 2 annual reports · 2025 to 2026
Earnings calls
42 calls · May 2016 to Sep 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Sep 1, 2026
- FY2026 Q4Jun 3, 2026
- FY2026 Q3Feb 17, 2026
- FY2026 Q2Nov 18, 2025
- FY2026 Q1Aug 19, 2025
- FY2025 Q4May 21, 2025
- FY2025 Q3Feb 18, 2025
- FY2025 Q2Nov 19, 2024
- FY2025 Q1Aug 20, 2024
- FY2024 Q4May 23, 2024
- FY2024 Q3Feb 20, 2024
- FY2024 Q2Dec 8, 2023
- FY2024 Q1Aug 22, 2023
- FY2023 Q4May 25, 2023
- FY2023 Q3Feb 21, 2023
- FY2023 Q2Nov 22, 2022
Executive media
15 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews12 · May 2020 to Sep 2026
- Other appearances3 · Mar 2021 to Sep 2024
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.